1397237-98-7 Usage
Uses
Used in Pharmaceutical Synthesis:
5-Bromo-4-fluoro-2-methoxybenzenamine is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drug compounds with potential therapeutic effects.
Used in Agrochemical Production:
In the agrochemical industry, 5-Bromo-4-fluoro-2-methoxybenzenamine is used as a building block in the creation of various agrochemicals, contributing to the development of effective products for agricultural applications.
Used in Medicinal Chemistry Research:
5-Bromo-4-fluoro-2-methoxybenzenamine is employed as a research compound in medicinal chemistry, where it is studied for its potential to form biologically active molecules that could be used in the treatment of various diseases and conditions.
Used in Organic Synthesis:
As a versatile chemical building block, 5-Bromo-4-fluoro-2-methoxybenzenamine is used in organic synthesis for the preparation of a range of biologically active molecules, expanding the scope of chemical compounds available for further research and application.
Safety Note:
Due to its potential health hazards, 5-Bromo-4-fluoro-2-methoxybenzenamine should be handled with care in a laboratory setting, adhering to proper safety protocols to minimize risks to researchers and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 1397237-98-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,9,7,2,3 and 7 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1397237-98:
(9*1)+(8*3)+(7*9)+(6*7)+(5*2)+(4*3)+(3*7)+(2*9)+(1*8)=207
207 % 10 = 7
So 1397237-98-7 is a valid CAS Registry Number.
1397237-98-7Relevant academic research and scientific papers
THERAPEUTIC COMPOUNDS AND METHODS OF USE
-
Paragraph 0612; 0615; 0616, (2021/05/21)
The invention relates to compounds and methods of using said compounds, as well as pharmaceutical compositions containing such compounds, for treating diseases and conditions mediated by TEAD, such as cancer.
CARBOXAMIDE AND SULFONAMIDE DERIVATIVES USEFUL AS TEAD MODULATORS
-
Paragraph 0395-0402, (2020/03/29)
The invention is concerned with the compounds of formula (I) and formula (II): and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of using the compounds of formula (I) and formula (II) as well as pharmaceutical compositions containing such compounds. The compounds are useful in treating diseases and conditions mediated by TEAD, such as cancer.
ACLY INHIBITORS AND USES THEREOF
-
Paragraph 00777, (2020/06/01)
The present invention provides compounds useful as inhibitors of ATP citrate lyase (ACLY), compositions thereof, and methods of using the same.
ASK1 INHIBITOR AND PREPARATION METHOD AND USE THEREOF
-
Paragraph 0370, (2020/01/02)
The present disclosure relates to a compound as shown in formula (II), a tautomer or a pharmaceutically acceptable salt thereof, and disclosed is the use thereof in preparing a drug for treating an ASK1-associated disease.
7-HYDROXY-INDOLINYL ANTAGONISTS OF P2Y1 RECEPTOR
-
Paragraph 00200, (2014/02/16)
The present invention provides compounds of Formula (I): Formula (I) as defined in the specification and compositions comprising any of such novel compounds. These compounds are antagonists of P2Y1 receptor which may be used medicaments.
